The role of halogen substitution in classical cannabinoids: A CB1 pharmacophore model

被引:0
|
作者
Nikas S.P. [1 ]
Grzybowska J. [1 ]
Papahatjis D.P. [2 ]
Charalambous A. [1 ]
Banijamali A.R. [1 ,3 ]
Chari R. [1 ]
Fan P. [1 ]
Kourouli T. [2 ]
Lin S. [1 ]
Nitowski A.J. [3 ]
Marciniak G. [1 ]
Guo Y. [1 ]
Li X. [1 ]
Wang C.-L.J. [4 ]
Makriyannis A. [1 ]
机构
[1] Department of Pharmaceutical Sciences, Center for Drug Discovery, University of Connecticut, Storrs, CT 06269
[2] Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Athens 116-35
[3] Crompton Corp., Middlebury
[4] DuPont Merek Co., Wilmington
基金
美国国家卫生研究院;
关键词
CB1 cannabinoid receptors; Halogen substitution; Tetrahydrocannabinol;
D O I
10.1208/aapsj060430
中图分类号
学科分类号
摘要
The presence of halogens within the classical cannabinoid structure leads to large variations in the compounds' potencies and affinities for the CB1 receptors. To explore the structure activity relationships within this class of analogs we have used a series of halogen-substituted (-)-Δ8-tetrahydrocannabinol analogs and compared their affinities for the CB1 cannabinoid receptor. Our results indicate that halogen substitution at the end-carbon of the side chain leads to an enhancement in affinity with the bulkier halogens (Br, I) producing the largest effects. Conversely, 2-iodo substitution on the phenolic ring leads to a 2-fold reduction in affinity while iodo-substitution in the C1′-position of the side chain lowers the compound's affinity for CB1 by more than 8-fold. The pharmacophoric requirements resulting from halogen-substitution are explored using computer modeling methods. Copyright ©2003. All Rights Reserved.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats
    Tyler, K
    Hillard, CJ
    Greenwood-Van Meerveld, B
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 409 (02) : 207 - 211
  • [42] Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors
    Grassin-Delyle, S.
    Naline, E.
    Buenestado, A.
    Faisy, C.
    Alvarez, J-C
    Salvator, H.
    Abrial, C.
    Advenier, C.
    Zemoura, L.
    Devillier, P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (11) : 2767 - 2777
  • [43] Cannabinoids and muscle weakness - Investigating the function of CB1 receptors in mammalian skeletal muscle
    Olah, T.
    Bodnar, D.
    Toth, A.
    Fodor, J.
    Kovacs, A.
    Farkas, A.
    Nadro, B.
    Szentesi, P.
    Csernoch, L.
    ACTA PHYSIOLOGICA, 2014, 211 : 82 - 83
  • [44] Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model
    Grim, T. W.
    Morales, A. J.
    Thomas, B. F.
    Wiley, J. L.
    Endres, G. W.
    Negus, S. S.
    Lichtman, A. H.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 362 (01): : 210 - 218
  • [45] Role of the cannabinoid receptor 1 (CB1) in fear adaptation
    Wotjak, Carsten T.
    ALCOHOL, 2011, 45 (03) : 270 - 270
  • [46] Cannabinoids induce apoptosis through CB1 and CB2 receptor activation in human colon cancer cells
    Cianchi, F.
    Cortesini, C.
    Magnelli, L.
    Papucci, L.
    Schiavone, N.
    Capaccioli, S.
    Lulli, M.
    Trallori, G.
    Fabbroni, V
    Masini, E.
    Perigli, G.
    Manera, C.
    ANNALS OF ONCOLOGY, 2007, 18 : VII33 - VII34
  • [47] Cannabinoids induce apoptosis through CB1 and CB2 receptor activation in human colon cancer cells
    Cianchi, F.
    Cortesini, C.
    Magnelli, L.
    Papucci, L.
    Schiavone, N.
    Capaccioli, S.
    Lulli, M.
    Trallori, G.
    Perigli, G.
    Masini, E.
    EJC SUPPLEMENTS, 2007, 5 (04): : 245 - 245
  • [48] The binding affinities of synthetic cannabinoids newly emerged as alternatives to marijuana at the cannabinoid CB1 and CB2 receptors
    Kikura-Hanajiri, Ruri
    Uchiyama, Nahoko
    Hakamatsuka, Takashi
    TOXICOLOGY LETTERS, 2014, 229 : S100 - S100
  • [49] In silico analysis of the interactions of CB ligands with their receptors: Towards the development of a consensus pharmacophore model for synthetic cannabinoids
    Sears, Robert
    McInnes, Campbell
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [50] Molecular signaling of synthetic cannabinoids: Comparison of CB1 receptor and TRPV1 channel activation
    Andersen, Haley K.
    Walsh, Kenneth B.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 907